EUVIMEDSkopri EUVIMED
Kohortenstudie

Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients

Mohamed H Eldesouki iD, Mohammad Kloub iD, Khaled Elfert iD, Ahmed Ibrahim iD, Madhusudan Grover, Swapna Gayam

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1537-1548

DOI: 10.1111/apt.70602 ↗

At a glance

Kohortenstudie in Alimentary Pharmacology & Therapeutics, published online on 2026-03-13. Written by Mohamed H Eldesouki and 5 co-authors. Institution: Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA. Major MEDLINE topics: Irritable Bowel Syndrome, Enteritis, Dyspepsia. Cited 2 times so far (Crossref); 44 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Infection enteritis is associated with the development of irritable bowel syndrome (IBS) and functional dyspepsia.

Aim

This study aimed to examine the long‐term risk of IBS and functional dyspepsia, and associated health care utilisation following infection enteritis.

Methods

We conducted a retrospective cohort study using TriNetX U.S. Network. Adults with infection enteritis were identified and matched to controls, balancing demographics and comorbidities. Primary outcomes were the risk of incident IBS and functional dyspepsia diagnoses at 1, 5, and 10 years. Secondary outcomes were rates of IBS‐ and functional dyspepsia‐related medications, endoscopy, abdominal imaging, and hospitalizations. Pathogen‐specific and multivariate analyses were performed to assess variations in IBS risk.

Results

After matching, 202,244 patients were identified in each study cohort. At 1 year of follow‐up, the infection enteritis cohort had higher rates of IBS (RR = 2.35; 95% CI: 2.14–2.59), functional dyspepsia (RR = 2.02; 95% CI: 1.84–2.22), use of IBS‐related medications (RR = 1.29; 95% CI: 1.26–1.31), functional dyspepsia‐related medications (RR = 1.56; 95% CI: 1.55–1.59), abdominal imaging (RR = 2.42; 95% CI: 2.29–2.54), and Oesophagogastroduodenoscopy/colonoscopy (RR = 1.57; 95% CI: 1.50–1.65). These risks remained significantly higher in the IE cohort at 5 and 10 years. Salmonella/Shigella (RR = 6.48), and Giardia lamblia (RR = 5.05) had the highest risk of developing incident IBS.

Conclusion

Infection enteritis was associated with increased risk of IBS and functional dyspepsia, rates of related medication use, and greater healthcare utilisation.

Subjects

MeSH terms (MEDLINE)

Irritable Bowel SyndromeEnteritisDyspepsiaHumansFemaleMaleRetrospective StudiesAdultMiddle AgedRisk FactorsCohort StudiesAgedIncidence

Author keywords

functional dyspepsiahealthcare utilisationinfection enteritispost‐infection irritable bowel syndrome

Authors and institutions

  • Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
  • Division of Gastroenterology and Hepatology, West Virginia University, Morgantown, West Virginia, USA.
  • Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Division of Gastroenterology and Hepatology, Enteric Neuroscience Program, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Mohamed H Eldesouki, Mohammad Kloub, Khaled Elfert, Ahmed Ibrahim

Cite

APA

Eldesouki, M. H., Kloub, M., Elfert, K., Ibrahim, A., Grover, M., & Gayam, S. (2026). Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients. Alimentary Pharmacology & Therapeutics, 63(11), 1537-1548. https://doi.org/10.1111/apt.70602

Vancouver

Eldesouki MH, Kloub M, Elfert K, Ibrahim A, Grover M, Gayam S. Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients. Alimentary Pharmacology & Therapeutics. 2026;63(11):1537-1548. doi:10.1111/apt.70602

BibTeX
@article{Eldesouki2026,
  author = {Eldesouki, Mohamed H and Kloub, Mohammad and Elfert, Khaled and Ibrahim, Ahmed and Grover, Madhusudan and Gayam, Swapna},
  title = {Cohort Study: Long‐Term Risk and Healthcare Burden of Irritable Bowel Syndrome Following Infection Enteritis in 202,244 Patients},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {11},
  pages = {1537--1548},
  doi = {10.1111/apt.70602}
}
Start for free →